These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 36179418)
21. Nuclear IL-33 Plays an Important Role in IL-31‒Mediated Downregulation of FLG, Keratin 1, and Keratin 10 by Regulating Signal Transducer and Activator of Transcription 3 Activation in Human Keratinocytes. Dai X; Shiraishi K; Muto J; Utsunomiya R; Mori H; Murakami M; Sayama K J Invest Dermatol; 2022 Jan; 142(1):136-144.e3. PubMed ID: 34293350 [TBL] [Abstract][Full Text] [Related]
22. IL-33 down-regulates CLDN1 expression through the ERK/STAT3 pathway in keratinocytes. Ryu WI; Lee H; Bae HC; Jeon J; Ryu HJ; Kim J; Kim JH; Son JW; Kim J; Imai Y; Yamanishi K; Jeong SH; Son SW J Dermatol Sci; 2018 Jun; 90(3):313-322. PubMed ID: 29534857 [TBL] [Abstract][Full Text] [Related]
23. Morus alba fruits attenuates atopic dermatitis symptoms and pathology in vivo and in vitro via the regulation of barrier function, immune response and pruritus. Kim HM; Kang YM; Jin BR; Lee H; Lee DS; Lee M; An HJ Phytomedicine; 2023 Jan; 109():154579. PubMed ID: 36610150 [TBL] [Abstract][Full Text] [Related]
24. Naringenin ameliorates atopic dermatitis by inhibiting inflammation and enhancing immunity through the JAK2/STAT3 pathway. Tian L; Wang M; Wang Y; Li W; Yang Y Genes Genomics; 2024 Mar; 46(3):333-340. PubMed ID: 37837514 [TBL] [Abstract][Full Text] [Related]
25. Anti-chitinase-3-like 1 antibody attenuated atopic dermatitis-like skin inflammation through inhibition of STAT3-dependent CXCL8 expression. Yu JE; Jeon SH; Kim MJ; Kim DH; Koo JK; Kim TH; Kim B; Yoon JY; Lim YS; Park SR; Yeo IJ; Yun J; Son DJ; Han SB; Lee YS; Hong JT Br J Pharmacol; 2024 Sep; 181(17):3232-3245. PubMed ID: 38745399 [TBL] [Abstract][Full Text] [Related]
26. The Expression and Regulation of Interleukin-33 in Human Epidermal Keratinocytes: A New Mediator of Atopic Dermatitis and Its Possible Signaling Pathway. Du HY; Fu HY; Li DN; Qiao Y; Wang QW; Liu W J Interferon Cytokine Res; 2016 Sep; 36(9):552-62. PubMed ID: 27348082 [TBL] [Abstract][Full Text] [Related]
27. IL‑18 knockout alleviates atopic dermatitis‑like skin lesions induced by MC903 in a mouse model. Chen JL; Niu XL; Gao YL; Ma L; Gao XH; Chen HD; Qi RQ Int J Mol Med; 2020 Aug; 46(2):880-888. PubMed ID: 32626950 [TBL] [Abstract][Full Text] [Related]
28. Polyozellin alleviates atopic dermatitis-like inflammatory and pruritic responses in activated keratinocytes and mast cells. Jeong NH; Lee S; Choi JK; Choi YA; Kim MJ; Lee HS; Shin TY; Jang YH; Song KS; Kim SH Biomed Pharmacother; 2020 Feb; 122():109743. PubMed ID: 31918284 [TBL] [Abstract][Full Text] [Related]
29. Nuclear IL-33 Plays an Important Role in the Suppression of FLG, LOR, Keratin 1, and Keratin 10 by IL-4 and IL-13 in Human Keratinocytes. Dai X; Utsunomiya R; Shiraishi K; Mori H; Muto J; Murakami M; Sayama K J Invest Dermatol; 2021 Nov; 141(11):2646-2655.e6. PubMed ID: 33865911 [TBL] [Abstract][Full Text] [Related]
30. Gomisin M2 Ameliorates Atopic Dermatitis-like Skin Lesions via Inhibition of STAT1 and NF-κB Activation in 2,4-Dinitrochlorobenzene/ Kang J; Lee S; Kim N; Dhakal H; Kwon TK; Kim EN; Jeong GS; Kim SH Molecules; 2021 Jul; 26(15):. PubMed ID: 34361560 [TBL] [Abstract][Full Text] [Related]
31. Bakuchicin attenuates atopic skin inflammation. Lim JS; Kim JY; Lee S; Choi JK; Kim EN; Choi YA; Jang YH; Jeong GS; Kim SH Biomed Pharmacother; 2020 Sep; 129():110466. PubMed ID: 32768955 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic effects of myricetin on atopic dermatitis in vivo and in vitro. Hou DD; Gu YJ; Wang DC; Niu Y; Xu ZR; Jin ZQ; Wang XX; Li SJ Phytomedicine; 2022 Jul; 102():154200. PubMed ID: 35671605 [TBL] [Abstract][Full Text] [Related]
33. IL-9 induces IL-8 production via STIM1 activation and ERK phosphorylation in epidermal keratinocytes: A plausible mechanism of IL-9R in atopic dermatitis. Hong CH; Chang KL; Wang HJ; Yu HS; Lee CH J Dermatol Sci; 2015 Jun; 78(3):206-14. PubMed ID: 25840641 [TBL] [Abstract][Full Text] [Related]
34. Interleukin 25, thymic stromal lymphopoietin and house dust mites in pathogenesis of atopic dermatitis. Jaworek AK; Szafraniec K; Zuber Z; Wojas-Pelc A; Jaworek J J Physiol Pharmacol; 2020 Apr; 71(2):. PubMed ID: 32776912 [TBL] [Abstract][Full Text] [Related]
35. ΔNp63 controls a TLR3-mediated mechanism that abundantly provides thymic stromal lymphopoietin in atopic dermatitis. Kubo T; Kamekura R; Kumagai A; Kawata K; Yamashita K; Mitsuhashi Y; Kojima T; Sugimoto K; Yoneta A; Sumikawa Y; Yamashita T; Sato N; Himi T; Ichimiya S PLoS One; 2014; 9(8):e105498. PubMed ID: 25171086 [TBL] [Abstract][Full Text] [Related]
36. Trifuhalol A Suppresses Allergic Inflammation through Dual Inhibition of TAK1 and MK2 Mediated by IgE and IL-33. Bong SK; Park NJ; Lee SH; Lee JW; Kim AT; Liu X; Kim SM; Yang MH; Kim YK; Kim SN Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077570 [TBL] [Abstract][Full Text] [Related]
37. Interleukin-33 in atopic dermatitis. Imai Y J Dermatol Sci; 2019 Oct; 96(1):2-7. PubMed ID: 31455506 [TBL] [Abstract][Full Text] [Related]
38. Increased serum human β-defensin-2 levels in atopic dermatitis: relationship to IL-22 and oncostatin M. Kanda N; Watanabe S Immunobiology; 2012 Apr; 217(4):436-45. PubMed ID: 22137028 [TBL] [Abstract][Full Text] [Related]
39. Kaempferol therapy improved MC903 induced-atopic dermatitis in a mouse by suppressing TSLP, oxidative stress, and type 2 inflammation. Nasanbat B; Uchiyama A; Amalia SN; Inoue Y; Yokoyama Y; Ogino S; Torii R; Hosoi M; Motegi SI J Dermatol Sci; 2023 Sep; 111(3):93-100. PubMed ID: 37393173 [TBL] [Abstract][Full Text] [Related]
40. Ghrelin Represses Thymic Stromal Lymphopoietin Gene Expression through Activation of Glucocorticoid Receptor and Protein Kinase C Delta in Inflamed Skin Keratinocytes. Jeong H; Chong HJ; So J; Jo Y; Yune TY; Ju BG Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409338 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]